Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 2 Study With IPI-926 in Patients With Myelofibrosis
This study has been completed.
Study NCT01371617   Information provided by Infinity Pharmaceuticals, Inc.

First Received on June 9, 2011.   Last Updated on November 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Myelofibrosis
Fibrosis, Bone Marrow
Additional conditions recognized in this trial
Fibrosis
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Myeloproliferative Disorders
Pathologic Processes
Interventions listed in this trial
IPI-926
Sponsors listed in this trial
Infinity Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services